Chinese American Cancer Survivors Writing Study

N

New York University (NYU)

Status

Enrolling

Conditions

Cancer

Treatments

Behavioral: Factual Writing
Behavioral: Expressive Helping
Behavioral: Expressive Writing

Study type

Interventional

Funder types

Other
NIH

Identifiers

NCT05456100
1K01MD014750 (U.S. NIH Grant/Contract)
20-0603

Details and patient eligibility

About

The Chinese American Cancer Survivors Writing Study is a Randomized Controlled Trial (RCT) testing the feasibility and efficacy of the Expressive Helping (EH) intervention among Chinese American cancer survivors.

Full description

Chinese Americans are one of the fastest growing immigrant groups in the United States, but there is still a lack of culturally-sensitive and linguistically-appropriate resources and interventions for this group. To address this gap, the investigators will examine the efficacy and feasibility of Expressive Helping, a writing intervention designed to lead participants to write about their cancer experiences. Participants will be adult cancer survivors of Chinese descent. After screening and consent, eligible participants will be enrolled in a 1:1:1 randomized controlled trial. Assessments of psychological symptoms will occur at baseline (prior to randomization), 1-month post-intervention, 3-months post-intervention, and 6-months post-intervention.

Enrollment

108 estimated patients

Sex

All

Ages

18 to 80 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Over 18 years old.
  • Prefer speaking in Mandarin Chinese or Cantonese, and able to read and write Simplified or Traditional Chinese.
  • Within 5 years after completing primary treatment or have completed primary treatment but still on medication for managing cancer-related symptoms.

Exclusion criteria

  • Difficulties with writing
  • Current active participation in support groups (i.e., attending more than once per week)

Trial design

Primary purpose

Supportive Care

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

108 participants in 3 patient groups

Expressive Helping
Experimental group
Description:
Participants complete a 20-minute expressive writing session once per week for the first three weeks. During Week 4, participants complete a 20-minute peer support writing session.
Treatment:
Behavioral: Expressive Helping
Expressive Writing
Active Comparator group
Description:
Participants complete a 20-minute expressive writing session once per week for four weeks.
Treatment:
Behavioral: Expressive Writing
Factual Writing
Active Comparator group
Description:
Participants complete a 20-minute factual writing about their cancer diagnosis and treatment every week for four weeks.
Treatment:
Behavioral: Factual Writing

Trial contacts and locations

0

Loading...

Central trial contact

William Tsai, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems